Verastem CEO Forrester Steps Down, Paterson Appointed President

Robert Forrester, president and CEO of Verastem (NASDAQ: [[ticker:VSTM]]) since 2013, has stepped down. The Needham, MA, company did not give a reason for Forrester’s decision but said that he would continue in an advisory role. Dan Paterson, chief operating officer of the cancer drug developer since 2014, has been appointed president in addition to his COO duties. He will lead Verastem while the board searches for Forrester’s successor. In other moves, CFO Rob Gagnon’s role was expanded to include chief business officer.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan